Pharmacy-based screening to detect persons at elevated risk of type 2 diabetes: a cost-utility analysis.

ABSTRACT:

Background

Early identification of people at elevated risk of type 2 diabetes (T2D) is an important step in preventing or delaying its onset. Pharmacies can serve as a significant channel to reach these people. This study aimed to assess the potential health economic impact of screening and recruitment services in pharmacies in referring people to preventive interventions.

Methods

A decision analytic model was constructed to perform a cost-utility analysis of the expected national health economic consequences (in terms of costs and quality-adjusted life years, QALYs) of a hypothetical pharmacy-based service where people screened and recruited through pharmacies would participate in a digital lifestyle program. Cost-effectiveness was considered in terms of net monetary benefi

SUBMITTER: Jalkanen K 

PROVIDER: S-EPMC8418722 | biostudies-literature | 2021 Sep

REPOSITORIES: biostudies-literature